Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
1,007.00
-5.00 (-0.49%)
Jun 3, 2026, 3:30 PM JST

TYO:4570 Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,004969816794647
Revenue Growth (YoY)
3.61%18.75%2.77%22.72%7.47%
Cost of Revenue
298335300268271
Gross Profit
706634516526376
Selling, General & Admin
299300282289310
Research & Development
120119129179188
Operating Expenses
425425406474498
Operating Income
28120911052-122
Interest Expense
-1-1-1-1-
Interest & Investment Income
1--1-
Earnings From Equity Investments
----203-152
Currency Exchange Gain (Loss)
6-3843
Other Non Operating Income (Expenses)
14571228
EBT Excluding Unusual Items
301210124-135-243
Gain (Loss) on Sale of Investments
----130-
Asset Writedown
----14-7
Other Unusual Items
----1-
Pretax Income
301210124-280-250
Income Tax Expense
-28-39-6298
Net Income
329249186-289-258
Net Income to Common
329249186-289-258
Net Income Growth
32.13%33.87%---
Shares Outstanding (Basic)
99999
Shares Outstanding (Diluted)
99999
EPS (Basic)
35.3326.7419.97-31.03-27.70
EPS (Diluted)
35.3326.7419.97-31.03-27.70
EPS Growth
32.13%33.87%---
Free Cash Flow
26812411726-93
Free Cash Flow Per Share
28.7813.3112.562.79-9.99
Gross Margin
70.32%65.43%63.23%66.25%58.11%
Operating Margin
27.99%21.57%13.48%6.55%-18.86%
Profit Margin
32.77%25.70%22.79%-36.40%-39.88%
Free Cash Flow Margin
26.69%12.80%14.34%3.28%-14.37%
EBITDA
299224112--
EBITDA Margin
29.78%23.12%13.73%--
D&A For EBITDA
18152--
EBIT
28120911052-122
EBIT Margin
27.99%21.57%13.48%6.55%-18.86%